References
- Hardman JG, Limbird LE, Gilman AG, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 11th ed. New York: McGraw-Hill; 2006.
- Waring WS, Laing WJ, Good AM, Malkowska AM. Acute caffeine ingestion: clinical features in patients attending the emergency department and Scottish Poison Centre enquiries between 2000 and 2008. Scott Med J 2009; 54:3–6.
- McCarthy DM, Mycyk MB, DesLauriers CA. Hospitalization for caffeine abuse is associated with abuse of other pharmaceutical products. Am J Emerg Med 2008; 26:799–802.
- Garriott JC, Simmons LM, Poklis A, Mackell MA. Five cases of fatal overdose from caffeine-containing “Look-alike” drugs. J Anal Toxicol 1985; 9:141–144.
- Winek CL, Wahba W, Willimas K, Blenko J, Janssen J. Caffeine fatality: a case report. Forensic Sci Int 1985; 29:207–211.
- Mrvos RM, Reilly PE, Dean BS, Krenzelok EP. Massive caffeine ingestion resulting in death. Vet Hum Toxicol 1989; 31:571–572.
- Hedetoft C, Jenssen CH, Christensen MR, Christensen O. Fatal poisoning with Letigen. Ugeskr Laeger 1999; 161:6937–6938.
- Cannon ME, Cooke CT, McCarthy JS. Caffeine-induced cardiac arrhythmia: an unrecognised danger of healthfood products. Med J Aust 2001; 174:520–521.
- Kanstrup MH, Petersen AP. Fatal poisoning with Letigen. Ugeskr Laeger 2003; 165:239–240.
- Holmgren P, Nordén-Pettersson L, Ahlner J. Caffeine fatalities – four case reports. Forensic Sci Int 2004; 139:71–73.
- Kerrigan S, Lindsey T. Fatal caffeine overdose: two case reports. Forensic Sci Int 2005; 153:67–69.
- Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999; 51:83–133.
- Emohare O, Ratnam V. Multiple cardiac arrests following an overdose of caffeine complicated by penetrating trauma. Anaesthesia 2006; 61:54–56.
- Strubelt O, Diederich KW. Experimental treatment of the acute cardiovascular toxicity of caffeine. J Toxicol Clin Toxicol 1999; 37:29–33.
- Druid H, Holmgren P. A compilation of fatal and control concentrations in postmortem femoral blood. J Forensic Sci 1997; 42:79–87.
- Carrillo JA, Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet 2000; 39:127–153.
- Sweetman SC, ed. Martindale – The Complete Drug Reference. 36th ed. London, UK: The Pharmaceutical Press; 2009.
- Poon H, Elliot V, Bateman DN, Waring WS. Impact of legislative changes on patterns of antipsychotic prescribing and self-poisoning in Scotland: 2000–06. J Toxicol Sci 2007; 32:1–7.
- Sandilands EA, Bateman DN. Co-proxamol withdrawal has reduced suicide from drugs in Scotland. Br J Clin Pharmacol 2008; 66:290–293.
- Bateman DN, Gorman DR, Bain M, Inglis JHC, House FR, Murphy D. Legislation restricting paracetamol sales and patterns of self-harm and death from paracetamol-containing preparations in Scotland. Br J Clin Pharmacol 2006; 62:573–581.
- Hawkins LC, Edwards JN, Dargan PI. Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom. Drug Saf 2007; 30:465–479.
- Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Cotreau MM, Harmatz JS, Shader RI. Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol 1997; 37:693–703.
- The International Association of Forensic Toxicology (TIAFT). Therapeutic and toxic drug concentrations. http://www.tiaft.org. Accessed 16 February 2010.